Journal article
Manipulations of Redox Metabolism for Enhancing Radiation Therapy Responses: A Historical Perspective and Novel Hypothesis
Seminars in radiation oncology, Vol.29(1), pp.1-5
01/2019
DOI: 10.1016/j.semradonc.2018.10.010
PMCID: PMC6709524
PMID: 30573179
Abstract
Since the recognition during the 20th century that cancer cells demonstrated fundamental alterations in the regulation of oxidative and glycolytic metabolism, many basic as well as translational scientists have proposed that targeting metabolic differences in cancer versus normal cells could be exploited to improve cancer therapy outcomes. With the recognition that dysregulation of mitochondrial redox metabolism leads to the increased steady-state levels of superoxide and hydrogen peroxide which could contribute to both aging and cancer; radiation biologists have pursued many avenues of targeting oxidative metabolic pathways to both selectively radiosensitive cancer cells as well as protect normal tissues during cancer therapy. Recent advances in exploiting redox metabolism for improving radiochemotherapy both from a basic and translational science point of view are the focus of the papers in this current issue of Seminars in Radiation Oncology. The historical perspective underlying these areas of research as well as a unifying hypothesis for further advancing this research into clinical trials will be presented in this overview.
Details
- Title: Subtitle
- Manipulations of Redox Metabolism for Enhancing Radiation Therapy Responses: A Historical Perspective and Novel Hypothesis
- Creators
- Douglas R Spitz - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Free Radical Metabolism and Imaging Program, Holden Comprehensive Cancer Center, B180 Medical Laboratories, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242.. Electronic address: douglas-spitz@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Seminars in radiation oncology, Vol.29(1), pp.1-5
- DOI
- 10.1016/j.semradonc.2018.10.010
- PMID
- 30573179
- PMCID
- PMC6709524
- NLM abbreviation
- Semin Radiat Oncol
- ISSN
- 1053-4296
- eISSN
- 1532-9461
- Publisher
- United States
- Grant note
- P01 CA217797 / NCI NIH HHS P30 CA086862 / NCI NIH HHS R01 CA182804 / NCI NIH HHS
- Language
- English
- Date published
- 01/2019
- Academic Unit
- Pathology; Radiation Oncology
- Record Identifier
- 9984047621202771
Metrics
20 Record Views